These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6782651)

  • 1. The actions of carbenoxolone on enzymes and their relation to its therapeutic effect.
    Roberts NB; Taylor WH
    Scand J Gastroenterol Suppl; 1980; 65():11-7. PubMed ID: 6782651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The action of carbenoxolone on enzymes, with special reference to the pepsins and their secretion.
    Roberts NB; Walker V; Etherington DJ; Baron JH; McConnell RB; Taylor WH
    Acta Gastroenterol Belg; 1983; 46(9-10):448-58. PubMed ID: 6424375
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations.
    Peskar BM
    Scand J Gastroenterol Suppl; 1980; 65():109-14. PubMed ID: 6259713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci Mol Med; 1973 Aug; 45(2):213-24. PubMed ID: 4206390
    [No Abstract]   [Full Text] [Related]  

  • 5. Pepsins, peptic activity, and peptic inhibitors.
    Samloff IM
    J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of sodium carbenoxolone on the stability of cellular membranes.
    Symons AM; Parke DV
    Scand J Gastroenterol Suppl; 1980; 65():3-10. PubMed ID: 6937938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carbenoxolone: ulcer-healing and metabolic effects.
    Wright PA; Reed PI; Davies WA; St John DJ; Young GP; House FR; Gribble RJ; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():41-8. PubMed ID: 6937940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C
    Clin Ter; 1979 Mar; 88(6):605-19. PubMed ID: 157245
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of carbenoxolone and cimetidine on gastric mucin.
    Guslandi M; Cambielli M; Bierti L; Tittobello A
    Clin Ther; 1980; 3(1):40-2. PubMed ID: 6157471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Eur J Clin Invest; 1983 Aug; 13(4):351-6. PubMed ID: 6413222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbenoxolone and gastric Technetium-99m pertechnetate uptake in patients with gastric ulceration.
    Williams JG; Croft DN
    Scand J Gastroenterol Suppl; 1980; 65():29-33. PubMed ID: 6259714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Carbenoxolone and gastric secretion.
    Walker V; Taylor WH
    Lancet; 1975 Jun; 1(7920):1335. PubMed ID: 49532
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 19. Intragastric PCO2 in man and calculated gastric bicarbonate concentrations: effect of carbenoxolone sodium.
    Elder JB; Hearn AR
    Scand J Gastroenterol Suppl; 1980; 65():19-27. PubMed ID: 6782652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.